Skip to main content
logo
Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
2.775
-0.025 (-0.89%)
Aug 10, 2026, 11:39 AM EDT - Market open

Fate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
3231272113699825,601
Market Cap Growth
171.35%-39.78%-42.88%-62.43%-82.47%-29.78%
Enterprise Value
225.411.0816.91157.23654.825,100
Last Close Price
2.780.981.653.7410.0958.51

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
51.6719.0915.465.8110.19100.29
PB Ratio
1.810.610.661.002.038.25
P/TBV Ratio
1.840.560.591.002.028.17

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
36.150.161.242.476.8091.32

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.400.350.240.260.210.16
Net Debt / Equity Ratio
-0.55-0.61-0.61-0.57-0.67-0.74
Net Debt / EBITDA Ratio
0.770.931.011.231.112.37
Net Debt / FCF Ratio
0.911.121.571.531.152.35
Asset Turnover
0.020.020.030.100.120.07
Quick Ratio
5.725.677.348.114.167.68
Current Ratio
5.855.797.588.484.407.79
Return on Equity (ROE)
-67.15%-51.84%-54.21%-37.76%-48.46%-39.90%
Return on Assets (ROA)
-46.18%-38.89%-44.41%-31.44%-37.91%-28.11%
Return on Invested Capital (ROIC)
-123.97%-109.01%-124.77%-97.71%-129.68%-123.30%
Return on Capital Employed (ROCE)
-51.92%-43.12%-48.38%-35.99%-43.08%-31.52%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-1.02%-4.49%-15.86%-1.34%-2.19%-15.01%
Total Shareholder Return
-1.02%-4.49%-15.86%-1.34%-2.19%-15.01%
SEC Filings: 10-K · 10-Q